Impact Factor: 1.4

Percutaneous revascularization in dilated cardiomyopathy

Recic 23 056 F1

Apropos of the REVIVED BCIS2 trial: the interventional cardiologist’s view

José F. Díaz Fernández

REC Interv Cardiol. 2023;5:297-298

Apropos of the REVIVED BCIS2 trial: the clinician’s view

Ángel Manuel Iniesta Manjavacas

REC Interv Cardiol. 2023;5:299-301

Recic 23 058 F1

Original articles

Recic Uk 23 065 F3

Editorials


Original articles

Recic Uk 23 072 F3
Recic Uk 23 099 F3
Recic Uk 23 044 F1

Editorials

Recic 23 092 F2

Original articles


Special articles

Recic Uk 23 075 F2

Debate

Debate: Ablation vs lithotripsy in calcified coronary lesions

Recic 23 102 F1
Recic 23 100 F1